Novaliq’s innovative EyeSol® technology is based on novel and exclusive water-free excipients and opens open completely new and intriguing opportunities to cure, relief and prevent diseases in various indications:
EyeSol® substances are highly biocompatible and do not accumulate in human tissues
rich Pipeline with first- and best-in-class candidates for a variety of ocular and non-ocular therapies.
For our products we only use highly pure substances and raw materials from qualified manufacturers. We have extensively tested and proven their safety, efficacy and tolerability in close cooperation with the regulatory authorities in Europe and USA, both preclinically and clinically.